Mariani, A. ., Mohiuddin, S. ., Muller, P. ., Samarasekera, E. ., Swain, S. A., Mills, J. ., … Wonderling, D. . (2025). Using a Markov Model and Real-World Evidence to Identify the Most Cost-Effective Cholesterol Treatment Escalation Threshold for the Secondary Prevention of Cardiovascular Disease. Appl Health Econ Health Policy. http://doi.org/10.1007/s40258-025-00977-6
M. Lonergan
First name
M.
Last name
Lonergan
Farmer, A. J., Rodgers, L. R., Lonergan, M. ., Shields, B. ., Weedon, M. N., Donnelly, L. ., … Hattersley, A. T. (2016). Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database. Diabetes Care. http://doi.org/10.2337/dc15-1194
Dennis, J. M., Henley, W. E., Weedon, M. N., Lonergan, M. ., Rodgers, L. R., Jones, A. G., … Hattersley, A. T. (2018). Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data. Diabetes Care. http://doi.org/10.2337/dc18-0344